Literature DB >> 1507329

Efficacy of second generation lithotriptors: a multicenter comparative study of 2,206 extracorporeal shock wave lithotripsy treatments with the Siemens Lithostar, Dornier HM4, Wolf Piezolith 2300, Direx Tripter X-1 and Breakstone lithotriptors.

A F Bierkens1, A J Hendrikx, V J de Kort, T de Reyke, C A Bruynen, E R Bouve, T V Beek, P Vos, H V Berkel.   

Abstract

Extracorporeal shock wave lithotripsy (ESWL) has become the treatment of choice for urinary calculi. The good results of the first generation Dornier HM3 lithotriptor stimulated the development of second generation machines. A multicenter trial is presented involving the Siemens Lithostar, Dornier HM4, Wolf Piezolith 2300, Direx Tripter X-1 and Breakstone lithotriptor to compare the therapeutic efficacy of second generation machines. Treatment results were best for calculi less than 2 cm. in diameter. Although the second generation lithotriptors are comparable to each other, none of the machines provided a success rate comparable to that of the first generation unmodified Dornier HM3 lithotriptor. The 5 machines differed mainly in types of stones treated in relation to imaging system, use of anesthesia, use of auxiliary procedures and hospitalization but overall success rates were similar. We conclude that second generation ESWL is less effective than first generation ESWL.

Entities:  

Mesh:

Year:  1992        PMID: 1507329     DOI: 10.1016/s0022-5347(17)36814-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Reduction of bubble cavitation by modifying the diffraction wave from a lithotripter aperture.

Authors:  Yufeng Zhou
Journal:  J Endourol       Date:  2012-03-26       Impact factor: 2.942

2.  Air pockets trapped during routine coupling in dry head lithotripsy can significantly decrease the delivery of shock wave energy.

Authors:  Yuri A Pishchalnikov; Joshua S Neucks; R Jason VonDerHaar; Irina V Pishchalnikova; James C Williams; James A McAteer
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

3.  A heuristic model of stone comminution in shock wave lithotripsy.

Authors:  Nathan B Smith; Pei Zhong
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

4.  Shock wave lithotripsy of urinary calculi with Lithocut C-3000 in a small center.

Authors:  L Daehlin; M Hellang; N M Ulvik
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  The patients perspective of extracorporeal shock wave lithotripsy.

Authors:  N Mahmood; W Turner; K Rowgaski; D Almond
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

6.  How painful are shockwave lithotripsy and endoscopic procedures performed at outpatient urology clinics?

Authors:  Byong Chang Jeong; Hyoung Keun Park; Cheol Kwak; Seong-June Oh; Hyeon Hoe Kim
Journal:  Urol Res       Date:  2005-06-22

7.  Evaluation of the LithoGold LG-380 lithotripter: in vitro acoustic characterization and assessment of renal injury in the pig model.

Authors:  Yuri A Pishchalnikov; James A McAteer; James C Williams; Bret A Connors; Rajash K Handa; James E Lingeman; Andrew P Evan
Journal:  J Endourol       Date:  2013-02-06       Impact factor: 2.942

8.  Assessment of a modified acoustic lens for electromagnetic shock wave lithotripters in a swine model.

Authors:  John G Mancini; Andreas Neisius; Nathan Smith; Georgy Sankin; Gaston M Astroza; Michael E Lipkin; W Neal Simmons; Glenn M Preminger; Pei Zhong
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

9.  Comparison of the effectiveness and safety of MPL 9000 and Lithostar Modularis shockwave lithotriptors: treatment results of 263 children.

Authors:  Yilmaz Aksoy; Tevfik Ziypak; Turgut Yapanoglu
Journal:  Urol Res       Date:  2009-03-10

10.  Extracorporeal shockwave lithotripsy under sedoanalgesia for treatment of kidney stones in infants: a single-center experience with 102 cases.

Authors:  Senol Adanur; Tevfik Ziypak; Ali Haydar Yılmaz; Huseyin Kocakgol; Mehmet Aksoy; Turgut Yapanoglu; Ozkan Polat; Yılmaz Aksoy
Journal:  Int Urol Nephrol       Date:  2014-07-31       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.